Achieved profitability in 3Q standalone; recovery driven by HAR, PFR, and DMX. 3Q cumulative revenue up 12.8% Year-over-Year, 3Q net income returned to a profit of 320 million yen. Full-year plan unchanged: operating income 740 million yen, progress 83.1%. New product news including NEURIG.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6694","jir_company_name":"Zoom Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/6694-20261111-02.pdf","jir_short_summary":"Achieved profitability in 3Q standalone; recovery driven by HAR, PFR, and DMX. 3Q cumulative revenue up 12.8% Year-over-Year, 3Q net income returned to a profit of 320 million yen. Full-year plan unchanged: operating income 740 million yen, progress 83.1%. New product news including NEURIG.","jir_summary":"### Overview of Performance\nProfitability improvements continued in the standalone 3Q, with a turnaround from an operating loss in the same period last year to an operating profit. Recovery across key categories expanded to HAR, PFR, and DMX, and actual sales in North America also improved. 3Q cumulative revenue increased Year-over-Year, and operating income remained in the black. As planned for the full year, operating income is 740 million yen with a progress rate of 83.1%, and the dividend forecast is unchanged.\n\n### Outlook and Topics\nThere were neural-focused demos centered on NEURIG and announcements of new products, garnering increased interest from guitar communities domestically and internationally. By region and product, expansion of DMX and PFR continued, and recovery breadth expanded mainly in North America and Europe. The full-year forecast is maintained for now, while monitoring impacts from external factors.","jir_financial_highlights":"Revenue: Unknown (Year-over-Year +12.8%)\nOperating Income: Unknown (Progress rate 83.1%, 3Q cumulative turned profitable)\nQuarterly Net Income: Unknown (3Q cumulative returned to profit)\nEBITDA: Unknown (3Q cumulative 1,220 million yen)","jir_category":"","jir_hashtags":"#ConsideringShareBuyback, #Earnings, #NEURIG, #NewProductAnnouncement","jir_key_figures":"Revenue: Unknown\nOperating Income: Unknown\nDividend per Share: Unknown","jir_meta_title":"Zoom Corporation: Third Quarter FY Dec 2026 Financial Summary Including NEURIG | November 2026","jir_meta_description":"Supplementary materials for Zoom Corporation's third quarter of the fiscal year ending December 2026. 3Q returned to profitability, recovery in HAR, PFR, and DMX, full-year forecasts maintained. Includes new product information such as NEURIG.","jir_og_title":"Zoom Corporation: 3Q Financial Summary and New Products including NEURIG","jir_og_description":"3Q profitability, Year-over-Year revenue increase, reporting of profit improvements and full-year progress. Key new product news including NEURIG is also summarized.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":60853,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-149265","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n